% alzhub.org library filter
% Source: https://alzhub.org/research?category=drug_development&author=Talbot+K
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{rhea2024-38095516,
  author  = {Rhea, E. M. and Babin, A. and Thomas, P. and Omer, M. and Weaver, R. and Hansen, K. and Banks, W. A. and Talbot, K.},
  title   = {{Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases}},
  journal = {Tissue barriers},
  year    = {2024},
  doi     = {10.1080/21688370.2023.2292461},
  pmid    = {38095516},
  url     = {https://doi.org/10.1080/21688370.2023.2292461}
}

@article{talbot2014-24529520,
  author  = {Talbot, K. and Wang, H. Y.},
  title   = {{The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2014},
  doi     = {10.1016/j.jalz.2013.12.007},
  pmid    = {24529520},
  url     = {https://doi.org/10.1016/j.jalz.2013.12.007}
}

@article{salameh2020-32755557,
  author  = {Salameh, T. S. and Rhea, E. M. and Talbot, K. and Banks, W. A.},
  title   = {{Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics}},
  journal = {Biochemical pharmacology},
  year    = {2020},
  doi     = {10.1016/j.bcp.2020.114187},
  pmid    = {32755557},
  url     = {https://doi.org/10.1016/j.bcp.2020.114187}
}